Melanoma Clinical Trials in North Carolina

Showing 101-120 of 146 trials

Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec

NCT02014441

The primary objective was to estimate the proportion of participants with detectable talimogene laherparepvec deoxyribonucleic acid (DNA) in the blood and urine at any time after administration of talimogene laherparepvec within the first 3 cycles.

Melanoma

Amgen61 participantsStarted Apr 2014

Tampa, Florida, United States • Indianapolis, Indiana, United States • Louisville, Kentucky, United States +11 more locations

COMPLETEDPHASE257 miles

Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma

NCT01673854

The purpose of this study is to assess the safety profile of vemurafenib, 960 mg, administered for 6 weeks, followed by ipilimumab monotherapy in patients with BRAF V600 mutated advanced/metastatic melanoma.

Melanoma

Bristol-Myers Squibb70 participantsStarted Sep 2012

Beverly Hills, California, United States • Jacksonville, Florida, United States • Orlando, Florida, United States +11 more locations

Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec

Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma

Melanoma Trials in Other Cities

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma

Phase II, 2nd Line Melanoma - RAND Monotherapy

Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery

Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma

Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung

Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

A Study of Tasisulam in Treating Participants With Malignant Melanoma

LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma

CCI-779 in Treating Patients With Metastatic Melanoma

SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma

Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma

A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )

Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone

Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)

A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady State

Other Conditions in North Carolina